Loading...

AstraZeneca PLC

AZNCF•PNK
Healthcare
Drug Manufacturers - General
$189.90
$-2.60(-1.35%)
U.S. Market opens in NaNh NaNm

AstraZeneca PLC (AZNCF) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap294.4B
P/E Ratio28.60
EPS (TTM)$6.03
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$199.33
3 Months$170.12
1 Year Target$174.35

AZNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $174.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.60 and a market capitalization of 294.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-7.25%
1-Month Change
-1.35%
3-Month Change
2.38%
6-Month Change
12.14%
Year-to-Date (YTD) Change
3.95%
1-Year Change
44.62%
3-Year Change
28.96%
5-Year Change
91.20%
All-Time (Max) Change
375.94%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

943,000 Employees
IPO DateFeb 13, 2009
CountryGB

Frequently Asked Questions